We have previously demonstrated that an intradermal (i.d.)immunization with CTB and a model antigen promotes an efficient IFN-γ+ CD4+ T-cell response (27), that increase the survival of mice challenged with melanoma associated with a CD4+ Trm response (28–30). This evidence concerns the gene CD4 and melanoma.